Tags

70 pages

KOSDAQ

APR (Medicube): The Beauty Tech Giant Going Global

Pharma Research Products: The PDRN Pioneer Behind Rejuran

Korean Stocks: 8 Names That Beat 5+ Screeners

Pearl Abyss After 5M Copies: Why 7.5M Is the New Floor

APR: The Medicube Empire Reshaping Global Beauty Tech

NextBiomedical: Nexpowder Downside, Nexphere-F Upside

Pharma Research Products: The PDRN Pioneer Behind Rejuran

KOSPI Closes Weak as Samsung Drags Breadth

APR Beauty Stock: Medicube, AGE-R and Korea's New Beauty Leader

Pearl Abyss: Crimson Desert Hits 4M and ₩223B Profit